Skip to content

Clinical trials

Observational Carcinoma, Non-Small-Cell Lung trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Observational Country / region: Germany Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20094
20122
20143
20153
20167
20173
20182
20193
20202
20211
20223
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting9
Unknown status3
Not yet recruiting2
Active, not recruiting2
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Boehringer Ingelheim4
iOMEDICO AG3
Bristol-Myers Squibb2
Hoffmann-La Roche2
OncoHost Ltd.2
Onkovis GmbH2
Pierre Fabre Pharma GmbH2
AIO-Studien-gGmbH1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung41
Lung Neoplasms6
Breast Neoplasms5
Melanoma4
Neoplasm Metastasis4
Small Cell Lung Carcinoma4
Carcinoma3
Neoplasms3
Carcinoma, Renal Cell2
Colonic Neoplasms2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.